Medicines & supplements – Current GIS Alerts 2026
Found 734 alerts in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Osporil
The National Medicines Institute found, in batch ZD033, particles visible to the naked eye in two of twenty inspected vials of the infusion solution. Potential effects: embolism, inflammatory reactions, complications after intravenous administration.
Osporil
The National Medicines Institute found in this batch of the medicinal product the presence of particles visible to the naked eye in two of twenty tested vials, causing the batch to fail quality requirements for solution appearance. Potential effects: post-infusion complications, inflammatory reactions, embolism by particles, lack of safety during infusion.
Liść Senesu
Fragments of plastics were detected in the tested sample of the batch and the product failed the requirement for the parameter “presence of mould, live and dead pests and their residues.” Potential effects: mechanical damage, irritation of the gastrointestinal tract, complications requiring medical intervention.
Liść Senesu
It was found that the product does not meet the requirement for the parameter "presence of mould, live and dead pests and their residues"; NIL testing detected fragments of plastics, which are foreign components not allowed in the medicinal product. Potential effects: contamination with foreign bodies, risk of gastrointestinal injury, infection.
Risperidone Teva
Testing by the National Medicines Institute showed out-of-specification results for the release parameter and particle size analysis; the critical role of active substance release for the product’s efficacy and safety was emphasized. Potential effects: lack of treatment efficacy, possible adverse reactions or therapy-related complications.
Risperidone Teva
The National Medicines Institute found an out-of-specification result for the release parameter at specific time points and temperature; the product does not meet the established quality requirements. Potential effects: lack of therapeutic efficacy or unpredictable drug action.
Risperidone Teva
Testing by the National Medicines Institute (OMCL) showed an out-of-specification result for the release parameter at a defined time point and temperature, meaning the product does not meet quality requirements and concerns a critical parameter affecting the drug’s action. Potential effects: lack of therapeutic efficacy or its disturbance, possible clinical complications.
Polibiotic
The detected non-compliance in appearance, physical properties and water content may affect the product’s quality and safety of use; therefore a risk to human health cannot be excluded. Potential effects: lack of therapeutic efficacy or undesirable skin reactions.
Polibiotic
The non-compliance in the parameters of dosage form and properties or water content may affect the quality of this product and the safety of its use, and therefore a risk to human health resulting from leaving these batches on the market cannot be excluded. Potential effects: reduced treatment effectiveness, possible skin irritation or other adverse skin reactions.
Strepsils z miodem i cytryną
Initially, a quality defect was suspected due to the presence of a foreign body in the blister cavity of the lozenge; it was later determined to be a local contamination caused by caramelization of the base mass containing sucrose, glucose and honey. Potential effects: minimal risk of irritation or unacceptable taste/appearance.
Euvax B
The need to verify circumstances related to a reported adverse post-vaccination reaction associated with potential administration of the medicinal product. Analysis of the collected documentation did not confirm a threat to public health. Potential effects: possible more severe post-vaccination reactions and a risk to patients’ health.
Reparil Gel N
Suspicion of failure to meet established quality requirements for the parameter “aescinol content”; out-of-specification stability results for representative batches indicated excessively high initial aescinol content in the finished product. Potential effects: possible reduced treatment effectiveness or increased adverse reactions.
Propolis Forte dietary supplement, 30 orange-flavored tablets
Possible presence of metal fragments in the tablets. Potential effects: cuts, choking, internal injuries.
Paracetamol Hasco
A non-compliance was found – non-uniform impurity content in the active substance used to manufacture the product batches, which may affect product quality and safety of use. Potential effects: possible adverse reactions, toxicity or reduced treatment safety.
Gripblocker Express
Non-uniform impurity content was found in the active substance used to manufacture the product batches, which may affect product quality and safety of use, and a risk to human health cannot be excluded. Potential effects: possible adverse reactions, poisoning, or other health complications.
Paracetamol Hasco
Non-uniform impurity content was found in the active substance used to manufacture the product batches, which may result in failure to meet quality requirements and the medicine’s safety of use. Potential effects: adverse reactions, reduced treatment effectiveness, therapy complications.
Gripblocker Express
Non‑uniform levels of impurities were found in the active substance used to manufacture the product batches, which may affect product quality and safety of use; a risk to human health cannot be excluded. Potential effects: adverse reactions, poisoning, lack of therapeutic efficacy.
Paracetamol Hasco
Non-compliance was found regarding non-uniform impurity content in the active substance used to manufacture the product batches, which may affect product quality and the safety of its use, posing a potential risk to human health. Potential effects: possible health risk, lack of efficacy or adverse reactions.
Paracetamol Hasco
Detected non-uniform impurity content in the active substance used to manufacture the product batches, which may affect product quality, safety of use, and a health risk to humans cannot be excluded. Potential effects: possible adverse reactions, toxic effects, or lack of therapeutic efficacy.
Maść szałwiowa
Incorrect packaging labeling – missing correct marketing authorization number. Potential effects: impaired access to information on authorization and safety; possible incorrect use.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.